These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5396486)

  • 1. Antiviral activity of 9-beta-D-arabinofuranosyladenine. VI. Effect of delayed treatment on herpes simplex virus in mice.
    Miller FA; Sloan BJ; Silverman CA
    Antimicrob Agents Chemother (Bethesda); 1969; 9():192-5. PubMed ID: 5396486
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.
    Sloan BJ; Miller FA; Ehrlich J; McLean IW; Machamer HE
    Antimicrob Agents Chemother (Bethesda); 1968; 8():161-71. PubMed ID: 4309848
    [No Abstract]   [Full Text] [Related]  

  • 3. New prodrugs of acyclic nucleosides with antiviral activity.
    Winkelmann E; Winkler I; Rolly H; Rösner M; Jähne G
    Arzneimittelforschung; 1988 Nov; 38(11):1545-8. PubMed ID: 3265058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine.
    Sloan BJ; Miller FA; McLean IW
    Antimicrob Agents Chemother; 1973 Jan; 3(1):74-80. PubMed ID: 4790577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
    Klein RJ; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1974 Mar; 5(3):318-22. PubMed ID: 4840439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of U herpes zoster and herpes simplex with isoprinosine].
    Stenberg TH; Macotela Ruiíz E
    Prensa Med Mex; 1972; 37(3):159-60. PubMed ID: 4559678
    [No Abstract]   [Full Text] [Related]  

  • 7. Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine.
    Allen LB; Sidwell RW
    Antimicrob Agents Chemother; 1972 Sep; 2(3):229-33. PubMed ID: 4790562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters.
    Sidwell RW; Dixon GJ; Schabel FM; Kaump DH
    Antimicrob Agents Chemother (Bethesda); 1968; 8():148-54. PubMed ID: 5735359
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenine arabinoside therapy in corneal stromal disease and iritis due to herpes simplex.
    Brightbill FS; Kaufman HE
    Ann Ophthalmol; 1974 Jan; 6(1):25-32. PubMed ID: 4359979
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral activity of 9-beta-D-arabinofuranosyladenine. 3. Reduction in evidence of encephalitis in treated herpes Simplex-infected hamsters.
    Schardein JL; Sidwel RW
    Antimicrob Agents Chemother (Bethesda); 1968; 8():155-60. PubMed ID: 4309847
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
    Marks MI
    J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
    Levin MJ; Bacon TH; Leary JJ
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on virus-inhibiting substances of bacterial origin. IV. Antiviral substances extractable from Streptococcus faecalis: its in vivo effect.
    Fujisaki M; Uchida S; Kojima M; Hotta S; Hamada C; Maeyama Y
    Kobe J Med Sci; 1978 Jun; 24(2):115-23. PubMed ID: 101714
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
    Sundmacher R
    Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes encephalitis: controlled studies.
    Hirsch MS; Levin M; Chien LT
    Ann Intern Med; 1973 May; 78(5):779. PubMed ID: 4711782
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
    Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
    Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
    Enright AM; Prober C
    Herpes; 2003 Aug; 10(2):32-7. PubMed ID: 14577952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities and limits of chemotherapy of diseases caused by herpes simplex and varicella-zoster virus].
    Wassilew SW
    Hautarzt; 1983 Jan; 34(1):1-5. PubMed ID: 6841073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the therapy of ocular herpes simplex.
    Pavan-Langston D
    Int Ophthalmol Clin; 1973; 13(4):53-63. PubMed ID: 4784004
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.